Publications by authors named "Gary H Lyman"

100Publications

Randomized Controlled Trials vs Real-World Data in the COVID-19 Era: A False Narrative.

Cancer Invest 2020 Oct 22:1-13. Epub 2020 Oct 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2020.1841922DOI Listing
October 2020

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels.

Cancer Med 2020 Sep 20. Epub 2020 Sep 20.

Division of Hematology, Department of Medicine, John Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.3437DOI Listing
September 2020

COVID-19, Cancer, and Consequences: Where Are We Now?

Cancer Invest 2020 Sep 18;38(8-9):431-435. Epub 2020 Sep 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2020.1812174DOI Listing
September 2020

Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis.

Thromb Res 2020 Jul;191 Suppl 1:S79-S84

University of Washington, Seattle, WA, USA; Advanced Cancer Research Group, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0049-3848(20)30402-3DOI Listing
July 2020

Antiemetics: ASCO Guideline Update.

J Clin Oncol 2020 Aug 13;38(24):2782-2797. Epub 2020 Jul 13.

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01296DOI Listing
August 2020

Providing oncology care during the COVID-19 pandemic.

Authors:
Gary H Lyman

Clin Adv Hematol Oncol 2020 05;18(5):262-265

University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
May 2020

Crowdsourcing in Crisis: Rising to the Occasion.

JCO Clin Cancer Inform 2020 Jun;4:551-554

Department of Medicine, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.20.00054DOI Listing
June 2020

Anticoagulants for the treatment of venous thromboembolism in patients with cancer: A comprehensive systematic review, pairwise and network meta-analysis.

Crit Rev Oncol Hematol 2020 Aug 30;152:103005. Epub 2020 May 30.

Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2020.103005DOI Listing
August 2020

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Lancet 2020 06 28;395(10241):1907-1918. Epub 2020 May 28.

Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(20)31187-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255743PMC
June 2020

Financial Toxicity, Financial Abuse, or Financial Torture: Let's Call It What It is!

Cancer Invest 2020 Mar 4;38(3):139-142. Epub 2020 Mar 4.

Guest Editor, Cancer Investigation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2020.1735084DOI Listing
March 2020

Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.

Cancer 2020 Apr 30;126(8):1736-1748. Epub 2020 Jan 30.

Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32724DOI Listing
April 2020

Prophylaxis of febrile neutropenia with colony-stimulating factors: the first 25 years.

Curr Med Res Opin 2020 03 29;36(3):483-495. Epub 2019 Dec 29.

Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2019.1703665DOI Listing
March 2020

The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma.

Ann Hematol 2020 Jan 26;99(1):121-126. Epub 2019 Nov 26.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03860-2DOI Listing
January 2020

Letter in reply.

J Comp Eff Res 2019 11 19;8(15):1261-1263. Epub 2019 Nov 19.

Fred Hutchinson Cancer Center & The University of Washington, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2019-0095DOI Listing
November 2019

How biosimilars will impact costs and care in oncology.

Authors:
Gary H Lyman

Clin Adv Hematol Oncol 2019 Oct;17(10):544-547

Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
October 2019

Rumors of the Death of Biosimilars Have Been Greatly Exaggerated.

Cancer Invest 2019;37(8):325-326. Epub 2019 Sep 19.

Cancer Investigation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2019.1666515DOI Listing
October 2019

Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis.

J Thromb Haemost 2019 12 17;17(12):2141-2151. Epub 2019 Sep 17.

Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jth.14613DOI Listing
December 2019

Addressing oncologists' gaps in the use of biosimilar products.

Am J Manag Care 2019 06;25(6 Spec No.):SP188-SP191

View Article

Download full-text PDF

Source
June 2019

Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States.

Thromb Res 2019 Aug 16;180:37-42. Epub 2019 May 16.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2019.05.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661186PMC
August 2019

Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.

Support Care Cancer 2020 Feb 7;28(2):925-932. Epub 2019 Jun 7.

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04875-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954126PMC
February 2020

New Biosimilar Approvals for Myeloid Growth Factors and Anemia.

Authors:
Gary H Lyman

J Natl Compr Canc Netw 2019 05;17(5.5):622-624

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5016DOI Listing
May 2019

Biosimilars: what the oncologist should know.

Future Oncol 2019 Apr 22;15(10):1147-1165. Epub 2019 Feb 22.

Public Health Sciences and Research Divisions, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0728DOI Listing
April 2019

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

N Engl J Med 2019 02;380(8):720-728

From the Department of Hematology and Medical Oncology, Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland (A.A.K.); the Department of Medicine, Memorial Sloan Kettering Cancer Center (G.A.S., E.M.O.), and Weill Cornell Medical College (G.A.S., E.M.O.), New York; the Thrombosis Research Institute and University College London, London (A.K.K.); University of Texas M.D. Anderson Cancer Center, Houston (S.V.-R.), and U.S. Oncology Research-Texas Oncology, Tyler (H.A.Y.) - both in Texas; the Department of Medicine, Charité Universitätsmedizin Berlin, Berlin (H.R.); the Division of Hematology-Oncology, University of California Davis School of Medicine, Sacramento (T.W.), and the Keck School of Medicine, University of Southern California, Los Angeles (H.A.L.); the Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (M.B.S.); the University of Washington School of Medicine (D.A.G., N.M.K., G.H.L.), Advanced Cancer Research Group (N.M.K.), and Fred Hutchinson Cancer Research Center (G.H.L.), Seattle; Penn State Cancer Institute, Milton S. Hershey Medical Center, Hershey, PA (C.P.B.); the Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC (J.N.P.); Janssen Scientific Affairs, Titusville (P.W., P.B., S.K.), and Janssen Research and Development, Raritan (U.V.) - both in New Jersey; the Department of Medicine, McMaster University, Hamilton, ON, Canada (J.E.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (R.M.); and the Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston (K.A.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814630
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814630DOI Listing
February 2019

Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.

J Comp Eff Res 2019 04 21;8(5):289-304. Epub 2019 Jan 21.

Fred Hutchinson Cancer Center & The University of Washington, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2018-0137DOI Listing
April 2019

Febrile Neutropenia: An Ounce of Prevention or a Pound of Cure.

Authors:
Gary H Lyman

J Oncol Pract 2019 01;15(1):27-29

1 Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00750DOI Listing
January 2019

Lessons From Reporting National Performance Measures in a Regional Setting: Washington State Community Cancer Care Report.

J Oncol Pract 2018 12;14(12):e801-e814

Fred Hutchinson Cancer Research Center, Seattle, WA; Premera Blue Cross, Mountlake Terrace, WA; and University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00410
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00410DOI Listing
December 2018

American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions.

J Glob Oncol 2018 09 11;4:1-8. Epub 2017 Aug 11.

Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Doug Pyle, American Society of Clinical Oncology, Alexandria, VA; Eduardo L. Cazap, Sociedad Latinoamericana y del Caribe de Oncología Médica, Buenos Aires, Argentina; Nagi S. El Saghir, American University of Beirut Medical Center, Beirut, Lebanon; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Boston, MA; Clement Adebayo Adebamowo, Institute of Human Virology, Baltimore, MD; David R. Gandara, University of California Davis Comprehensive Cancer Center, Sacramento, CA; Julie Vose, University of Nebraska Medical Center, Omaha, NE; Sandra L. Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; and Peter Yu, Hartford HealthCare, Hartford, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180769PMC
September 2018

Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.

J Pain Symptom Manage 2018 11 17;56(5):699-708.e1. Epub 2018 Aug 17.

Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Pharmacy University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2018.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226016PMC
November 2018

Rationale, Opportunities, and Reality of Biosimilar Medications.

N Engl J Med 2018 08;379(7):694-695

Emory University, Atlanta, GA

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1808348
Publisher Site
http://dx.doi.org/10.1056/NEJMc1808348DOI Listing
August 2018

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary.

J Oncol Pract 2018 08;14(8):495-499

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00283DOI Listing
August 2018

External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer.

Support Care Cancer 2019 Mar 8;27(3):921-925. Epub 2018 Aug 8.

University of Connecticut School of Medicine, Farmington, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4380-1DOI Listing
March 2019

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline.

J Clin Oncol 2018 09 11;36(25):2647-2655. Epub 2018 Jun 11.

Gary H. Lyman and Heather Greenlee, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Ting Bao and Gary E. Deng, Memorial Sloan Kettering Cancer Center; Dawn L. Hershman, Columbia University Medical Center, New York; Karen M. Mustian, University of Rochester Medical Center, Rochester, NY; Angela M. DeMichele, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Judith M. Fouladbakhsh, Oakland University, Rochester, MI; Brigitte Gil, Lahey Hospital and Medical Center, Burlington, MA; Sami Mansfield, Cancer Wellness for Life, Shawnee, KS; Sarah Cannon Cancer Institute, Kansas City, MO; Dawn M. Mussallem, The Mayo Clinic, Jacksonville, FL; Erin Price, Smith Center for Healing and the Arts, Washington, DC; Susan Rafte, Houston, TX; and Lorenzo Cohen, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.2721DOI Listing
September 2018

Reply to S.D. Lucio.

J Clin Oncol 2018 07 30;36(20):2127. Epub 2018 May 30.

Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle WA; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; R. Donald Harvey, Emory University, Atlanta GA; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.1780DOI Listing
July 2018

Rationale, Opportunities, and Reality of Biosimilar Medications.

N Engl J Med 2018 May;378(21):2036-2044

From the Fred Hutchinson Cancer Research Center, Seattle (G.H.L.); Michiana Hematology Oncology, Mishawaka, IN (R.Z.); Emory University, Atlanta (R.D.H.); and the American Society of Clinical Oncology, Alexandria, VA (R.L.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMhle1800125DOI Listing
May 2018

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

J Clin Oncol 2018 08 22;36(23):2433-2443. Epub 2018 May 22.

Neelima Denduluri, The US Oncology Network, Virginia Cancer Specialists; Jamie N. Holloway, Georgetown Breast Cancer Advocates, Arlington; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Mariana Chavez-MacGregor and Sharon H. Giordano, University of Texas MD Anderson Cancer Center, Houston, TX; Melinda L. Telli, Stanford University School of Medicine, Stanford; Arti Hurria, City of Hope, Duarte, CA; Andrea Eisen and Maureen E. Trudeau, Sunnybrook Odette Cancer Centre; Andrea Eisen and Maureen E. Trudeau, Cancer Care Ontario, Toronto, Ontario, Canada; Stephanie L. Graff, Sarah Cannon Cancer Institute HCA Midwest Health, Kansas City, MO; Michael J. Hassett, Tari A. King, and Ann H. Partridge, Dana-Farber Cancer Institute; Tari A. King, Brigham & Women's Cancer Center, Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Antonio C. Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.8604
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.8604DOI Listing
August 2018

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

J Clin Oncol 2018 07 10;36(20):2017-2023. Epub 2018 May 10.

Annie M. Young, Andrea Marshall, Jenny Thirlwall, Catherine Hill, Danielle Hale, Janet A. Dunn, and Stavros Petrou, Warwick Clinical Trials Unit, University of Warwick; Oliver Chapman and Christopher J. Poole, University Hospitals Coventry and Warwickshire; Charles Hutchinson and Jeremy Dale, Warwick Medical School, University of Warwick, Coventry; Anand Lokare, Heart of England National Health Service Foundation Trust, Birmingham; Peter MacCallum, Queen Mary University of London; Ajay Kakkar, Thrombosis Research Institute, London; F.D. Richard Hobbs, University of Oxford, Oxford; Anthony Maraveyas, Hull York Medical School, Hull, United Kingdom; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; and Mark Levine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8034DOI Listing
July 2018

Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety.

J Clin Oncol 2018 06 9;36(18):1773-1776. Epub 2018 May 9.

Nicole M. Kuderer, Advanced Cancer Research Group, Seattle, WA; and Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.5592
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.5592DOI Listing
June 2018

Immune-related Adverse Events in Cancer Patients.

Acad Emerg Med 2018 07 25;25(7):819-827. Epub 2018 May 25.

Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/acem.13443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328011PMC
July 2018

Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.

Thromb Res 2018 04;164 Suppl 1:S112-S118

University of Washington, Seattle, WA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2018.01.028DOI Listing
April 2018

American Society of Clinical Oncology Statement: Biosimilars in Oncology.

J Clin Oncol 2018 04 14;36(12):1260-1265. Epub 2018 Feb 14.

Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.4893DOI Listing
April 2018

Oncology Clinical Pathways: Charting the Landscape of Pathway Providers.

J Oncol Pract 2018 03 7;14(3):e194-e200. Epub 2018 Feb 7.

Memorial Sloan Kettering Cancer Center, New York; Roswell Park Cancer Institute, Buffalo, NY; Michiana Hematology-Oncology, Mishawaka, IN; Center for Cancer and Blood Disorders, Fort Worth, TX; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; and City of Hope, Rancho Cucamonga, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.17.00033DOI Listing
March 2018

Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.

BMC Cancer 2018 01 6;18(1):44. Epub 2018 Jan 6.

Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, 1100 Fairview Ave N, Seattle, Washington, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3922-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756362PMC
January 2018

Chemotherapy Use at the End of Life in Uganda.

J Glob Oncol 2017 Dec 18;3(6):711-719. Epub 2017 Jan 18.

Daniel Low, Emily C. Merkel, Manoj Menon, Gary H. Lyman, and Corey Casper, University of Washington School of Medicine; Manoj Menon, Gary H. Lyman, Henry Ddungu, and Corey Casper, Fred Hutchinson Cancer Research Center, Seattle, WA; Henry Ddungu, Uganda Cancer Institute; and Elizabeth Namukwaya and Mhoira Leng, Makerere/Mulago Palliative Care Unit, Kampala, Uganda.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2016.007385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735970PMC
December 2017

Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.

Clin Lung Cancer 2018 03 28;19(2):e163-e169. Epub 2017 Oct 28.

Department of Medicine and Cancer Institute, Duke University Medical Center, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.10.013DOI Listing
March 2018

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2018 02 12;36(4):399-413. Epub 2017 Dec 12.

Sandra L. Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Mark B. Faries, The Angeles Clinic and Research Institute, Santa Monica; Alistair Cochran, University of California, Los Angeles Center for Health Services, Los Angeles, CA; Erin B. Kennedy, American Society of Clinical Oncology, Alexandria, VA; Sanjiv S. Agarwala, St Luke's Cancer Center, Easton; John M. Kirkwood, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Timothy J. Akhurst, Peter MacCallum Cancer Centre, Victoria, Australia; Charlotte Ariyan, Memorial Sloan Kettering Cancer Center, New York, NY; Charles M. Balch, MD Anderson Cancer Center, Houston, TX; Barry S. Berman, Broward Health, Fort Lauderdale; Jonathan S. Zager, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Keith A. Delman, Emory University, Atlanta, GA; Mark Gorman, Silver Spring, MD; Marc D. Moncrieff, Norfolk and Norwich University Hospital, Norwich, United Kingdom; and Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7724DOI Listing
February 2018

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update Summary.

J Oncol Pract 2018 04 12;14(4):242-245. Epub 2017 Dec 12.

Dartmouth-Hitchcock Medical Center, Lebanon, NH; American Society for Clinical Oncology, Alexandria, VA; and Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.028241DOI Listing
April 2018

Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study.

JNCI Cancer Spectr 2017 Sep 28;1(1):pkx009. Epub 2017 Nov 28.

Hematology/Oncology, Cleveland Clinic, Cleveland, OH (DPSS, MFK, KM, AAK); Hematology/Oncology, University of Washington, Seattle, WA (NMK, GHL); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (FAS); Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria (IP); Stroke Unit, Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy (GA); Jane Anne Nohl Devision of Hematology, University of Southern California, Los Angeles, CA (HAL); Respiratory and Intensive Care Medicine, Universite Paris Descartes, Paris, France (GM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkx009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649852PMC
September 2017

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.

Support Care Cancer 2018 01 22;26(1):7-20. Epub 2017 Sep 22.

Department of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3854-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827957PMC
January 2018

Emerging Opportunities and Challenges of Biosimilars in Oncology Practice.

Authors:
Gary H Lyman

J Oncol Pract 2017 09;13(9_suppl):7s-9s

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.026831DOI Listing
September 2017

Patient-reported outcomes in acute myeloid leukemia: Where are we now?

Blood Rev 2018 01 1;32(1):81-87. Epub 2017 Sep 1.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2017.08.010DOI Listing
January 2018

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Oct 31;35(28):3240-3261. Epub 2017 Jul 31.

Paul J. Hesketh, Lahey Hospital and Medical Center, Burlington; Kimberly Noonan, Dana-Farber Cancer Institute, Boston, MA; Mark G. Kris, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch and Stacie B. Dusetzina, University of North Carolina at Chapel Hill, Chapel Hill; Sally Y. Barbour, Duke University Medical Center, Durham, NC; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Virginia Beach; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Rebecca Anne Clark-Snow, University of Kansas Cancer Center, Westwood, KS; Cathy Eng, The University of Texas MD Anderson Cancer Center, Houston, TX; Dee Sparacio, Patient Representative, Hightstown, NJ; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kristopher Dennis, The Ottawa Hospital and University of Ottawa, Ottawa; L. Lee Dupuis, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Petra C. Feyer, Vivantes Clinics Neukoelln, Berlin; and Karin Jordan, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.4789DOI Listing
October 2017

Costs, Trends, and Related Factors in Treating Lung Cancer Patients in 67 Hospitals in Guangxi, China.

Cancer Invest 2017 May 3;35(5):345-357. Epub 2017 Apr 3.

c Division of Public Health Science , Fred Hutchinson Cancer Research Center and University of Washington , Seattle , Washington , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2017.1296156DOI Listing
May 2017

Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.

J Clin Oncol 2017 Jun 30;35(16):1845-1854. Epub 2017 Mar 30.

Kala Visvanathan, Johns Hopkins Bloomberg School of Public Health and Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD; Laura A. Levit and Clifford A. Hudis, American Society of Clinical Oncology, Alexandria, VA; Derek Raghavan, Carolinas HealthCare System, Charlotte, NC; Sandra Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Amylou Dueck, Mayo Clinic, Rochester, MN; and Gary H. Lyman, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6414DOI Listing
June 2017

American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in Oncology.

J Oncol Pract 2017 03 7;13(3):207-210. Epub 2017 Feb 7.

Michiana Hematology-Oncology PC, Mishawaka, IN; Roswell Park Cancer Institute, Buffalo, NY; The Center for Cancer and Blood Disorders, Fort Worth, TX; Charleston Area Medical Center, Charleston, WV; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Cancer Research Advocate, Grand Island, NE; American Society of Clinical Oncology, Alexandria, VA; and City of Hope, Rancho Cucamonga, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.019836DOI Listing
March 2017

Impact of the elimination of cost sharing for mammographic breast cancer screening among rural US women: A natural experiment.

Cancer 2017 Jul 14;123(13):2506-2515. Epub 2017 Feb 14.

University of North Carolina School of Global Public Health, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30629DOI Listing
July 2017

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

J Oncol Pract 2017 03 24;13(3):196-198. Epub 2017 Jan 24.

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; and Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.019992DOI Listing
March 2017

Reply to L. Del Mastro and A. Prat.

J Clin Oncol 2017 04 17;35(10):1139. Epub 2017 Jan 17.

Neelima Denduluri, Virginia Cancer Specialists, US Oncology Network, Arlington, VA; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Andrea Eisen, Sunnybrook Odette Cancer Centre, and Cancer Care Ontario, Toronto, Canada; Jamie N. Holloway, Arlington, VA; Arti Hurria, City of Hope, Duarte, CA; Tari A. King, Dana-Farber Cancer Institute, and Brigham & Women's Cancer Center; Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Melinda L. Telli, Stanford University, Palo Alto, CA; Maureen E. Trudeau, Sunnybrook Health Sciences Centre, and Cancer Care Ontario, Toronto, Canada; and Antonio C. Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.9758
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.9758DOI Listing
April 2017

Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.

Expert Rev Pharmacoecon Outcomes Res 2017 Feb 20;17(1):39-52. Epub 2017 Jan 20.

f Department of Health Policy and Management; Department of Biostatistics , Harvard T.H. Chan School of Public Health , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1276829DOI Listing
February 2017

Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.

JAMA Oncol 2017 07;3(7):996-998

Department of Medicine, University of Washington, Seattle2Center for Cancer Innovation, University of Washington, Seattle5Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.4983DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824236PMC
July 2017